Status:
COMPLETED
EEG Parameters Between Remimazolam- and Propofol-based Anesthesia
Lead Sponsor:
Yonsei University
Conditions:
Cholecystitis, Acute
Gallbladder Neoplasms
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
This is an observational study comparing perioperative quantitative EEG parameters between the conventional propofol/remifentanil and remimazolam/remifentanil. We aim to compare and analyze the differ...
Eligibility Criteria
Inclusion
- Patients aged 19 to 65 years who meet the American Society of Anesthesiologists (ASA) physical status classification 1-3 and undergo laparoscopic cholecystectomy at Severance Hospital.
Exclusion
- Pregnant women, individuals with arrhythmias, emergency surgeries, obesity (BMI \> 30), day-surgery, foreigners, and illiterate individuals.
Key Trial Info
Start Date :
June 26 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06178848
Start Date
June 26 2023
End Date
October 27 2023
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine
Seoul, South Korea